Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Sep;58(9):978-80.
doi: 10.1136/jcp.2004.023044.

CD56: a useful tool for the diagnosis of small cell lung carcinomas on biopsies with extensive crush artefact

K Kontogianni  1 , A G Nicholson, D Butcher, M N Sheppard
Affiliations

CD56: a useful tool for the diagnosis of small cell lung carcinomas on biopsies with extensive crush artefact

K Kontogianni et al. J Clin Pathol. 2005 Sep.

Abstract

Background/aims: The diagnosis of small cell lung carcinoma (SCLC) on bronchial biopsy is often problematical as a result of intense crush artefact. Several antibodies are now available to help in the diagnosis of SCLC and their value was assessed in this clinical situation.

Methods/results: Twenty cases of SCLC and 10 control cases (one non-Hodgkin lymphoma, three non-small cell carcinomas, one follicular reactive hyperplasia, and five chronic non-specific inflammations) with extensive crush artefact were stained using antibodies to CD56, MNF116, thyroid transcription factor 1 (TTF-1), and CD45. All SCLCs showed strong positive staining for CD56 in 75-100% of recognisable tumour cells, even in areas where there was extensive crush artefact. Eighteen of 20 cases were positive for TTF-1 and 16 of 20 were positive for MNF116 in the tumour cells, but both of these antibodies showed little or no staining in areas of crush artefact. Control cases comprising lymphoid cells were positive for CD45 in areas of crush artefact, but all cases of SCLC were negative.

Conclusion: CD56, along with markers for cytokeratins-TTF-1, and CD45-are useful in the diagnosis of SCLC in biopsies with extensive crush artefact and can help confirm the diagnosis in cases where features are equivocal.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) Bronchial biopsy showing extensively crushed cells staining diffusely for CD56. (B) Same bronchial biopsy showing positive staining for MNF116, although the extensively crushed cells show variable or little staining.
Figure 2
Figure 2
Bronchial biopsy showing extensively crushed cells staining diffusely for CD56.
Figure 3
Figure 3
Small cell carcinoma cells showing positive nuclear staining for thyroid transcription factor 1.
See this image and copyright information in PMC

References

    1. Thomas JS, Lamb D, Ashcroft T, et al. How reliable is the diagnosis of lung cancer using small biopsy specimens? Report of a UKCCCR lung cancer working party. Thorax 1993;48:1135–9. - PMC - PubMed
    1. Wilson RS, Lloyd RV. Detection of chromogranin in neuroendocrine cells with a monoclonal antibody. Am J Pathol 1984;115:458–68. - PMC - PubMed
    1. Gould VE, Wiedenmann B, Lee I, et al. Synaptophysin expression in neuroendocrine neoplasms as determined by immunocytochemistry. Am J Pathol 1987;126:243–57. - PMC - PubMed
    1. Said JW, Vimadalal S, Nash G, et al. Immunoreactive neuro-specific enolase, bombesin and chromogranin as markers for neuroendocrine lung tumors. Hum Pathol 1985;16:236–40. - PubMed
    1. Lantuejoul S, Moro D, Michalides RJ, et al. Neural cell adhesion molecule (NCAM) and NCAM-PSA expression in neuroendocrine lung tumors. Am J Surg Pathol 1998;22:1267–76. - PubMed